2:38 1. Run a temperament check before you act in a drawdown
The repeatable method
- When the portfolio is falling and you feel fear/frustration/the urge to "look good," don't go numb to the emotion — but don't act on it either. Pause.
- Ask whether a legendary long-term investor (Buffett/Lynch/Munger) would tell you it matters that you beat the index this YTD period. If not, the urge to change strategy is the emotion talking.
- Only then return to the fundamentals and decide. Reaction speed is the enemy; control over the reaction is the edge.
Here: down ~8% YTD and ~15% behind the S&P, with Micron ripping 15% a day, he names the frustration explicitly — then refuses to chase momentum or "high-grade" the book, because the Magellan investors who sold Lynch's dips earned far less than the fund.
Watch for
- An urge to switch into whatever's outperforming; a need to "look good every week"; selling at a low to buy what already ran — the exact Magellan-investor error.
26:06 2. Diagnose the drawdown — multiple compression vs a weakening growth engine
The repeatable method
- Decompose the decline: is the price down because earnings/growth are deteriorating, or because investors are paying a lower multiple for the same (or better) earnings?
- Quantify it — back out the implied multiple change from your aggregate earnings growth vs the price move (he maps ~−8% price on a flat engine to ~−20% multiple compression).
- Multiple compression on a healthy engine is "far less alarming" and self-correcting; deterioration in earnings/moat is the one that demands action.
Here: −3% YTD ⇒ ~−16% multiples, −5% ⇒ ~−17%, his −8% ⇒ ~−20% — "investors are giving them a lower multiple rating," not a verdict on the businesses.
Watch for
- Earnings rising while price falls; a forward P/E that keeps dropping purely on growth; no change in the underlying revenue/EPS trajectory.
29:19 3. Build a look-through table and track "earnings power owned"
The repeatable method
- Collapse the whole portfolio into one synthetic company: weight each holding's revenue/EPS growth by its position size to get a single blended growth rate.
- Sum the actual earnings your shares own — the dollar EPS attributable to your holdings — and project it forward a year.
- Judge health on these aggregate, price-independent numbers; if the blended engine grows faster than the S&P (~9–10%), the book is fine regardless of quotes.
Here: ~16% blended revenue growth, ~15% owned-EPS growth, and "earnings power owned" rising from ~$53,100 (2026) to ~$61,600 (2027) — "as if my portfolio is working a full-time job."
Watch for
- A blended growth rate above the index; rising owned-EPS year over year; the gap between that and the price is your margin of safety.
47:14 4. Stress-test each moat three ways — and act only when the moat, not the price, deteriorates
The repeatable method
- For every holding, ask not "are earnings up?" but "is the competitive moat getting wider or narrower?" — earnings can rise right up until a business is disrupted.
- Triangulate: get an AI model's objective read, write your own independent take (disagree where you have an edge), and cross-check a third party (Morningstar's moat trend).
- Reserve portfolio changes for names where the moat is genuinely impairing — "if a lot of the moats were getting weaker, I'd be changing positions."
Here: AI + his own analysis + Morningstar all land "stable to slightly strengthened" across the book; META/GOOGL clearly improving, DUOL the lone "under test" — so the conclusion is hold, not sell.
Watch for
- A holding where two of three reads say the moat is narrowing; a number that's rising only because disruption hasn't bitten yet (the BlackBerry pattern below).
17:03 5. Anchor to the earnings-follow-price rule; treat detachments as buys
The repeatable method
- Judge a holding by where its earnings-per-share will be in 5–10 years, not by money flows, headlines or momentum.
- Accept that price and EPS are ~100% correlated long-term but detach short-term (usually <5 years, at most ~10) when investors price in a future EPS change.
- When EPS keeps compounding but price has detached downward, that gap is the opportunity to buy — because cheapness eventually attracts buyers and "overwhelms negative stories."
Here: the MCD 1985→2026 chart overlays EPS on price (tight correlation, brief detachments like the 2020 dip that "recovered faster than EPS"); his portfolio's forward P/E falls 25.5×→21.9× on growth alone.
Watch for
- A quality name where EPS is rising but price is flat/down; a forward multiple compressing purely on growth; a "bad aura" narrative detached from the numbers.
48:04 6. Don't trust rising earnings alone — test for the BlackBerry trap
The repeatable method
- Remember that reported earnings can keep climbing for years while a moat is being hollowed out by a new technology.
- So pair the raw-numbers check with a subjective disruption question: is anything structurally able to cut into this company's earnings power soon?
- If the numbers are strong but the moat is being newly contested, downgrade conviction even before the financials roll over.
Here: BB — "BlackBerry's earnings continued to go up for a while until the iPhone took over and really cut into their earnings power" — the reason he runs the separate moat-trajectory test on each holding.
Watch for
- A new entrant/technology that lowers the barrier to a holding's core product (e.g. AI vs DUOL); strong trailing numbers masking an eroding moat.
Methods distilled from the self-hosted Qualtrim Studio portfolio-update video (transcript in transcript.txt) for personal study. Not investment advice. © Joseph Carlson / Qualtrim for source material.